seen from Belarus
seen from Italy
seen from United Kingdom
seen from United States
seen from Türkiye
seen from United States
seen from Malaysia
seen from China
seen from China
seen from China
seen from United States
seen from Egypt
seen from China
seen from China
seen from United States
seen from Malaysia
seen from United Kingdom
seen from Indonesia
seen from United States
seen from United Kingdom
AUPM 170, CA 170, PD-1-IN-1
AUPM 170, CA 170, PD-1-IN-1
(2S,3R)-2-(3-((S)-3-amino-1-(3-((R)-1-amino-2-hydroxyethyl)-1,2,4-oxadiazol-5-yl)-3-oxopropyl)ureido)-3-hydroxybutanoic acid Molecular Weight (MW) 360.33Formula C12H20N6O7CAS…
View On WordPress
Curis and Aurigene’s AUPM 170, CA 170
Curis and Aurigene’s AUPM 170, CA 170
1,2,4-oxadiazole and 1 ,2,4-thiadiazole compounds of formula (I): ONE EXAMPLE OR 1,3,4-oxadiazole and 1 ,3,4-thiadiazole compounds of formula (I): EXAMPLES PREDICTED AUPM 170, CA 170, AUPM-170, CA-170 Synthesis coming…………. WATCH THIS SPACE Aurigene Discovery Technologies Limited INNOVATOR Curis with the option to exclusively license Aurigene’s orally-available small molecule antagonist of…
View On WordPress
Curis and Aurigene’s AUPM 170, CA 170
Curis and Aurigene’s AUPM 170, CA 170
AUPM 170, CA 170, AUPM-170, CA-170
Synthesis coming………….
Curis with the option to exclusively license Aurigene’s orally-available small molecule antagonist of programmed death ligand-1 (PD-L1) in the immuno-oncology field
Addressing immune checkpoint pathways is a well validated strategy to treat human cancers and the ability to target PD-1/PD-L1 and other immune checkpoints with orally…
View On WordPress
